
Source briefing
Communicable disease threats report, 3 – 9 October, week 41
This issue of the Communicable disease threats report (CDTR) covers the period 3 - 9October 2026, and includes updates on respiratory virus epidemiology in the EU/EEA, pneumonia of unknown aetiology, Ebola, expert deployment, West Nile Virus, Crimean-Congo haemorrhagic…
Read →
Source briefing
Opinion/decision on a Paediatric investigation plan (PIP): Emgality, Galcanezumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: EMA/PE/0000227737
Opinion/decision on a Paediatric investigation plan (PIP): Emgality, Galcanezumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: EMA/PE/0000227737
Read →
Source briefing
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 7, Status: Authorised
Read →
Source briefing
Clinical trial applications advice pilot becomes permanent
The Accelerating Clinical Trials in the EU (ACT EU) advice pilot, which helps sponsors prepare clinical trial applications, will become a permanent initiative from January 2027…
Read →

Source briefing
John E. Malmstad, 84
At a meeting of the Faculty of Arts and Sciences on Oct. 6, 2026, the following tribute to the life and service of the late John E. Malmstad was spread…
Read →
Source briefing
Marcyliena H. Morgan, 75
At a meeting of the Faculty of Arts and Sciences on Oct. 6, 2026, the following tribute to the life and service of the late Marcyliena H. Morgan was spread…
Read →
Source briefing
Human medicines European public assessment report (EPAR): Zinmyleo, trilaciclib, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Zinmyleo, trilaciclib, Status: Application withdrawn
Read →
Source briefing
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Read →
Source briefing
A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study
by Zhengyang Zhu, Kejun Ren, Dong Wang, Yong Lv, Hua Jin, Lei Zhang, Yiping Wang Background The cardiovascular‑kidney‑metabolic (CKM) syndrome shows substantial heterogeneity in progression, yet existing biological age indices are not tailored to CKM pathways. We developed…
Read →